Literature DB >> 23830466

Clinical perspectives of cancer stem cell research in radiation oncology.

Rebecca Bütof1, Anna Dubrovska, Michael Baumann.   

Abstract

Radiotherapy has a proven potential to eradicate cancer stem cells which is reflected by its curative potential in many cancer types. Considerable progress has been made in identification and biological characterisation of cancer stem cells during the past years. Recent biological findings indicate significant inter- and intratumoural and functional heterogeneity of cancer stem cells and lead to more complex models which have potential implications for radiobiology and radiotherapy. Clinical evidence is emerging that biomarkers of cancer stem cells may be prognostic for the outcome of radiotherapy in some tumour entities. Perspectives of cancer stem cell based research for radiotherapy reviewed here include their radioresistance compared to the mass of non-cancer stem cells which form the bulk of all tumour cells, implications for image- and non-image based predictive bio-assays of the outcome of radiotherapy and a combination of novel systemic treatments with radiotherapy.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Radiation oncology; Radiobiology

Mesh:

Year:  2013        PMID: 23830466     DOI: 10.1016/j.radonc.2013.06.002

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  36 in total

1.  Chemoradiation therapy reduces aldehyde dehydrogenase 1 expression in cervical cancer but does not improve patient survival.

Authors:  Yin Lv; Lin Yang; Fan Wang
Journal:  Med Oncol       Date:  2015-04-03       Impact factor: 3.064

2.  Radiobiological characteristics of cancer stem cells from esophageal cancer cell lines.

Authors:  Jian-Lin Wang; Jing-Ping Yu; Zhi-Qiang Sun; Su-Ping Sun
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 3.  Concise Review: Prostate Cancer Stem Cells: Current Understanding.

Authors:  Sergej Skvortsov; Ira-Ida Skvortsova; Dean G Tang; Anna Dubrovska
Journal:  Stem Cells       Date:  2018-08-27       Impact factor: 6.277

Review 4.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

5.  Disturbance of redox status enhances radiosensitivity of hepatocellular carcinoma.

Authors:  Chao Sun; Zhen-Hua Wang; Xiong-Xiong Liu; Li-Na Yang; Yali Wang; Yang Liu; Ai-Hong Mao; Yuan-Yuan Liu; Xin Zhou; Cui-Xia Di; Lu Gan; Hong Zhang
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 6.  Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials.

Authors:  C Norman Coleman; Geoff S Higgins; J Martin Brown; Michael Baumann; David G Kirsch; Henning Willers; Pataje G S Prasanna; Mark W Dewhirst; Eric J Bernhard; Mansoor M Ahmed
Journal:  Clin Cancer Res       Date:  2016-05-06       Impact factor: 12.531

Review 7.  Does the mobilization of circulating tumour cells during cancer therapy cause metastasis?

Authors:  Olga A Martin; Robin L Anderson; Kailash Narayan; Michael P MacManus
Journal:  Nat Rev Clin Oncol       Date:  2016-08-23       Impact factor: 66.675

8.  Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway.

Authors:  Meng Wang; Jing Han; Lynnette Marcar; Josh Black; Qi Liu; Xiangyong Li; Kshithija Nagulapalli; Lecia V Sequist; Raymond H Mak; Cyril H Benes; Theodore S Hong; Kristin Gurtner; Mechthild Krause; Michael Baumann; Jing X Kang; Johnathan R Whetstine; Henning Willers
Journal:  Cancer Res       Date:  2017-02-15       Impact factor: 12.701

9.  Migration and invasion in B16-F10 mouse melanoma cells are regulated by Nrf2 inhibition during treatment with ionizing radiation.

Authors:  Yali Gao; Zishen Zhao; Xiaoyin Meng; Hongguag Chen; Guojun Fu
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

10.  Prognostic value of SUR in patients with trimodality treatment of locally advanced esophageal carcinoma.

Authors:  Rebecca Bütof; Frank Hofheinz; Klaus Zöphel; Julia Schmollack; Christina Jentsch; Sebastian Zschaeck; Jörg Kotzerke; Jörg van den Hoff; Michael Baumann
Journal:  J Nucl Med       Date:  2018-08-30       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.